SEC Form 4 · accession 0001547522-15-000140
OxySure Therapeutics, Inc. · OXYS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Cox
Director
Period of report
Aug 12, 2015
Accepted (ET)
Aug 14, 2015 · 10:34 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001413797
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Aug 12, 2015 | P | 12,000 | $0.4285 | A | 12,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Aggregate price for 12,000 shares purchased on the open market over multiple transactions.